论文信息 - Reply to letter to the editor: Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention - 字舞流文

Reply to letter to the editor: Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

L. Køber | M. Lamberts | J. Olesen | C. Torp-Pedersen | G. Gislason | G. Lip | S. Kristensen | M. L. Hansen | Annemarie Olsen | A. Mikkelsen | C. B. Christensen | G. Gislason

[1] L. Køber,et al. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. , 2013, Journal of the American College of Cardiology.

[2] G. Lip,et al. Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy , 2013, Thrombosis and Haemostasis.

[3] G. Lip,et al. Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes , 2013, Thrombosis and Haemostasis.

[4] Tom Adriaenssens,et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial , 2013, The Lancet.

[5] D. Atar,et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. , 2011, European heart journal.

[6] Deepak L. Bhatt,et al. Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting , 2011, Thrombosis and Haemostasis.

[7] H. Arnesen,et al. Warfarin, aspirin, or both after myocardial infarction. , 2002, The New England journal of medicine.